Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Aldevron Constructs Plasmid Manufacturing Facility
Aldevron is building a $30 million plasmid manufacturing facility in Fargo, N.D. The 70,000-sf project will feature 17,000 sf of modular cGMP cleanrooms, as well as ISO 8 processing suites with ISO 7 suites for cell banking and fermentation. The facility will feature airlocked, unidirectional personnel flow within the cGMP production area, single-pass air for all product dispensing and cell banking suites, and integrated facility and environmental monitoring systems.
Fraunhofer Opens Project Centre for Biomedical Engineering and Advanced Manufacturing
Fraunhofer Institute for Cell Therapy and Immunology opened the Project Centre for Biomedical Engineering and Advanced Manufacturing (BEAM) in March of 2018 in Hamilton, Ontario. Located in the McMaster Innovation Park, the $33 million project involved the renovation and fit-out of an existing warehouse to create a 20,000-sf innovation center offering research, office, and manufacturing space. An additional 20,000 sf on the second floor will house laboratories and offices in the future.
Taconic Biosciences Opens East Greenbush Headquarters
Taconic Biosciences, a breeder of mice and rats for medical research, opened its 8,000-sf headquarters in February of 2018 in East Greenbush, N.Y. Located in the Cancer Research Center Building on the University at Albany Health Sciences campus, the facility is strategically sited to optimize relationships with key stakeholders and customers. The space houses the company's leadership team, as well as members of its product strategy, marketing, human resources, finance, quality, customers service, and business technology units.
Boston University's National Emerging Infectious Diseases Lab Receives BSL-4 Research Approval
Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) has received final approval from the Boston Public Health Commission to conduct research at Biosafety Level 4 (BSL-4). After years of scrutiny by regulatory agencies and city, state, and federal officials, the $200 million laboratory will now be able to work with approved BSL-4 pathogens such as Ebola and Marburg.
Georgia State University Plans Biocontainment Research Facility
Georgia State University is planning to construct a $35 million biocontainment research facility in Atlanta. Located on the Downtown campus, the 55,000-sf building will provide BSL-3 and BSL-4 laboratories for the study of infectious diseases and select agents. The project, which will be the first academic BSL-4 facility in the Southeast, will include open research labs, offices, and support space.